title: Changes in peritoneal dialysis practices in Canada 1996-1999.
abstract: OBJECTIVE
  Over the past decade, clinical studies and clinical practice guidelines have suggested the use of higher small solute clearance targets for patients on peritoneal dialysis (PD). This study asks whether these recommendations have translated into changes in clinical prescription of PD.
  
  
  METHODS
  Data were collected annually from 1996 to 1999 on all prevalent dialysis patients in 24 Canadian centers, accounting for approximately 40% of the Canadian chronic dialysis population. Approximately a third of these patients were on PD. Full details of each patient's prescription were recorded, with particular attention to dwell volumes and frequency of exchanges for continuous ambulatory PD (CAPD) and to total treatment volumes and day dwells for automated PD (APD). The most recent Kt/V and creatinine clearance values available were recorded for each patient and the overall results for each year were compared to present treatment recommendations.
  
  
  METHODS
  24 university- and community-based hospitals.
  
  
  RESULTS
  From 1996 to 1999, the use of APD, relative to CAPD, grew from 14% to 28% of all PD patients. Among CAPD patients, the proportion using dwell volumes greater than 2 L rose from 14% to 32%, and the proportion doing more than 4 dwells per day rose from 16% to 28%. The mean daily volume of prescribed fluid for CAPD patients increased from 8.3 to 9.1 L. As a result, the proportion of patients achieving a weekly Kt/V above 2.0 rose from 54% to 72%, and those receiving a Kt/V less than 1.7 fell from 22% to 10%. For creatinine clearance, those exceeding 60 L per week rose from 63% to 73%. For APD, the mean treatment volume rose from 11.8 L in 1996 to plateau at about 13.4 L in 1998 and 1999. However, the proportion of patients receiving more than 1 day dwell grew from 31% in 1998 to 40% in 1999, and the proportion that were "day dry" fell from 25% to 17%. For APD, the proportion of patients with a Kt/V above 2.0 rose from 67% to 77%, and with a creatinine clearance above 60 L, from 62% to 70%. The proportion with no recent clearance value recorded fell during the course of the study, from 45% to 27%.
  
  
  CONCLUSIONS
  There was a marked change in PD prescription practices in Canada during the second half of the 1990s. This occurred in response to clinical studies and publication of guidelines. There is room for further improvement, especially with respect to the proportion of patients that did not have regular clearance measurements made.
authors.affiliation: London Health Sciences Centre, ON, Canada.
authors.forename: Rafael A
authors.initials: RA
authors.lastname: Perez
authors.forename: Peter G
authors.initials: PG
authors.lastname: Blake
authors.forename: Kailash A
authors.initials: KA
authors.lastname: Jindal
authors.forename: Kimberly
authors.initials: K
authors.lastname: Badovinac
authors.forename: Lilyanna
authors.initials: L
authors.lastname: Trpeski
authors.forename: Stanley S A
authors.initials: SS
authors.lastname: Fenton
mesh_terms: D002170:Canada / Q000453:epidemiology; D003404:Creatinine / Q000378:metabolism; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000706:statistics & numerical data*; D017410:Practice Guidelines as Topic; D011364:Professional Practice / Q000639:trends*
chemical_list: D003404:Creatinine